Inspire Medical Systems is a medical technology company focused on the development and commercialization of solutions for patients with obstructive sleep apnea. Co.'s proprietary Inspire system is the United States Food and Drug Administration-approved neurostimulation technology that provides a treatment for moderate to severe obstructive sleep apnea. Co. has developed a solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Co. sells its Inspire system to hospitals and ambulatory surgery centers in the United States and in select countries in Europe through a direct sales organization. The INSP stock yearly return is shown above.
The yearly return on the INSP stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2019 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the INSP annual return calculation with any dividends reinvested as applicable (on ex-dates).
|